Cargando…

Protective effect of dihydromyricetin revents fatty liver through nuclear factor-κB/p53/B-cell lymphoma 2-associated X protein signaling pathways in a rat model

Dihydromyricetin is the major flavonoid in vine tea, whose pharmacological action has attracted increasing attention in recent years. The triglyceride, albumin (ALB), alanine aminotransferase, aspartate aminotransferase, malondialdehyde, superoxide dismutase, glutathione (GSH), GSH peroxidase, tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lu, Zhang, Haifeng, Yan, Xiuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390035/ https://www.ncbi.nlm.nih.gov/pubmed/30592279 http://dx.doi.org/10.3892/mmr.2018.9783

Ejemplares similares

Des anciens du CERN rêvent d'un train sous le Mont-Blanc
Publicado: (2001)

Dihydromyricetin Inhibits Pseudorabies Virus Multiplication In Vitro by Regulating NF-κB Signaling Pathway and Apoptosis
por: Zhao, Xufan, et al.
Publicado: (2023)

Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
por: Matouk, Asmaa I., et al.
Publicado: (2023)

Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism
por: Silva, Joshua, et al.
Publicado: (2020)

Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease
por: LIN, ZHIHUI, et al.
Publicado: (2014)

IgE-Induced Mast Cell Activation Is Suppressed by Dihydromyricetin through the Inhibition of NF-κB Signaling Pathway
por: Chang, Tsong-Min, et al.
Publicado: (2021)

Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
por: Cheng, Quan-Cheng, et al.
Publicado: (2020)

Dihydromyricetin Attenuates Inflammation through TLR4/NF-kappaB Pathway
por: Jing, Nianshui, et al.
Publicado: (2019)

Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)

The Versatile Effects of Dihydromyricetin in Health
por: Li, Hongliang, et al.
Publicado: (2017)

Mechanism of Dihydromyricetin on Inflammatory Diseases
por: Sun, Yang, et al.
Publicado: (2022)

Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
por: Jing, Nianshui, et al.
Publicado: (2021)

Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity
por: Le, Liang, et al.
Publicado: (2016)

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
por: Wu, Bin, et al.
Publicado: (2017)

Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism
por: Zhang, Qingyu, et al.
Publicado: (2014)

Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway
por: Zhao, Yingchun, et al.
Publicado: (2021)

Protective Effect of Dihydromyricetin Against Lipopolysaccharide-Induced Acute Kidney Injury in a Rat Model
por: Wang, Jun-Tao, et al.
Publicado: (2016)

Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway
por: Yang, Zhousheng, et al.
Publicado: (2023)

A Case Report on Extruded Disc Acting as Buttonhole reventing Reduction in Traumatic Fracture and Lateral Dislocation of L1-l2 Vertebrae
por: Sundaram, P.Shanmuga, et al.
Publicado: (2014)

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
por: Wu, Jia-Zhen, et al.
Publicado: (2019)

Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity
por: Zhao, Libo, et al.
Publicado: (2017)

Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy
por: Chen, Yongbiao, et al.
Publicado: (2016)

Metabolomics of the Protective Effect of Ampelopsis grossedentata and Its Major Active Compound Dihydromyricetin on the Liver of High-Fat Diet Hamster
por: Fan, Lanlan, et al.
Publicado: (2020)

In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes
por: Liu, Lu, et al.
Publicado: (2017)

Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway
por: Chang, Yicong, et al.
Publicado: (2020)

Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor
por: Personnaz, Jean, et al.
Publicado: (2022)

Functional Redundancy of the Nuclear Factor κB Inhibitors IκBα and IκBβ
por: Cheng, Janet D., et al.
Publicado: (1998)

Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
por: Wu, Shixing, et al.
Publicado: (2013)

Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin
por: Xu, Yingqi, et al.
Publicado: (2017)

Atypical IκB proteins – nuclear modulators of NF-κB signaling
por: Schuster, Marc, et al.
Publicado: (2013)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells
por: Davis, R. Eric, et al.
Publicado: (2001)

Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
por: Zhang, Jingyao, et al.
Publicado: (2018)

Research progress of dihydromyricetin in the treatment of diabetes mellitus
por: Wang, Ziyuan, et al.
Publicado: (2023)

Cinnamaldehyde protects against rat intestinal ischemia/reperfusion injuries by synergistic inhibition of NF-κB and p53
por: Almoiliqy, Marwan, et al.
Publicado: (2020)

Nuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB
por: Ge, Wenjie, et al.
Publicado: (2021)

Protective role of Dihydromyricetin in Alzheimer’s disease rat model associated with activating AMPK/SIRT1 signaling pathway
por: Sun, Ping, et al.
Publicado: (2019)

Alginate Suppresses Liver Fibrosis Through the Inhibition of Nuclear Factor-κB Signaling
por: Xia, Ziqiang, et al.
Publicado: (2020)

NF-κB regulation: the nuclear response
por: Mankan, Arun K, et al.
Publicado: (2009)

Beyond NF-κB activation: nuclear functions of IκB kinase α
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5fsrfurp45no9urfuc061hljdm